Comendador, Rosalia R.

HRN: 18-18-75  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/05/2023
CO-AMOXICLAV 625MG (TAB)
05/05/2023
05/12/2023
PO
625 Mg
Every 12 Hours
T/C UTI
Waiting Final Action 
05/06/2023
CEFUROXIME 1.5GM (VIAL)
05/06/2023
05/13/2023
IVT
1.5g
Q8H
UTI

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: